Phospho-Smad3 (S423 + S425) Recombinant Rabbit Monoclonal Antibody [ST0493]
Usd: 385 Special Discount
Specification
Safety datasheet
Overview
Product Name
Phospho-Smad3 (S423 + S425) Recombinant Rabbit Monoclonal Antibody [ST0493]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic phospho-peptide corresponding to residues surrounding Ser423 and 425 of human Smad3.
Product Specificity
Phospho-SMAD3 (S423/S425) (ST0493) Rabbit mAb detects endogenous levels of SMAD3 only when dually phosphorylated at serines 423 and 425, and may detect SMAD2 phosphorylated at serines 465 and 467.
Species Reactivity
Human, Mouse
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P
Molecular Weight
Predicted band size: 48 kDa
Positive Control
A549 treated with 5ng/mL TGF-beta1 for 24 hours whole cell lysate, C2C12 treated with 5ng/mL TGF-beta1 for 24 hours whole cell lysate, HeLa starved overnight then treated with 10ng/mL TGF-β1 for 30 minutes cell lysate, NIH/3T3 starved overnight then treated with 10ng/mL TGF-β1 for 30 minutes cell lysate, A549, human large intestine tissue, mouse skin tissue, mouse kidney tissue.
Conjugation
unconjugated
Clone Number
ST0493
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000-1:5,000
-
IF-Cell
-
1:500
-
IF-Tissue
-
1:200
-
IHC-P
-
1:200-1:1,000
Target
Function
Smad proteins, the mammalian homologs of the Drosophila Mothers against dpp (Mad) have been implicated as downstream effectors of TGFβ/BMP signaling. Smad1 (also designated Madr1 or JV4-1), Smad5 and mammalian Smad8 (also designated Smad9 or MADH6) are effectors of BMP2 and BMP4 function while Smad2 (also designated Madr2 or JV18-1) and Smad3 are involved in TGFβ and activin-mediated growth modulation. Smad4 (also designated DPC4) has been shown to mediate all of the above activities through interaction with various Smad family members. Smad6 and Smad7 regulate the response to activin/TGFβ signaling by interfering with TGFβ-mediated phosphorylation of other Smad family members. Human Smad3 is subject to phosphorylation by TGFβ on specific amino acid residues, including Ser 208.
Background References
1. Marino FE et al. The inhibin/activin signalling pathway in human gonadal and adrenal cancers. Mol Hum Reprod 20:1223-37 (2014).
2. Tobar N et al. c-Jun N terminal kinase modulates NOX-4 derived ROS production and myofibroblasts differentiation in human breast stromal cells. BMC Cancer 14:640 (2014).
Sequence Similarity
Belongs to the dwarfin/SMAD family.
Post-translational Modification
Phosphorylated on serine and threonine residues. Enhanced phosphorylation in the linker region on Thr-179, Ser-204 and Ser-208 on EGF and TGF-beta treatment. Ser-208 is the main site of MAPK-mediated phosphorylation. CDK-mediated phosphorylation occurs in a cell-cycle dependent manner and inhibits both the transcriptional activity and antiproliferative functions of SMAD3. This phosphorylation is inhibited by flavopiridol. Maximum phosphorylation at the G(1)/S junction. Also phosphorylated on serine residues in the C-terminal SXS motif by TGFBR1 and ACVR1. TGFBR1-mediated phosphorylation at these C-terminal sites is required for interaction with SMAD4, nuclear location and transactivational activity, and appears to be a prerequisite for the TGF-beta mediated phosphorylation in the linker region. Dephosphorylated in the C-terminal SXS motif by PPM1A. This dephosphorylation disrupts the interaction with SMAD4, promotes nuclear export and terminates TGF-beta-mediated signaling. Phosphorylation at Ser-418 by CSNK1G2/CK1 promotes ligand-dependent ubiquitination and subsequent proteasome degradation, thus inhibiting SMAD3-mediated TGF-beta responses. Phosphorylated by PDPK1.; Acetylation in the nucleus by EP300 in the MH2 domain regulates positively its transcriptional activity and is enhanced by TGF-beta.; Poly-ADP-ribosylated by PARP1 and PARP2. ADP-ribosylation negatively regulates SMAD3 transcriptional responses during the course of TGF-beta signaling.; Ubiquitinated. Monoubiquitinated, leading to prevent DNA-binding. Deubiquitination by USP15 alleviates inhibition and promotes activation of TGF-beta target genes. Ubiquitinated by RNF111, leading to its degradation: only SMAD3 proteins that are 'in use' are targeted by RNF111, RNF111 playing a key role in activating SMAD3 and regulating its turnover (By similarity). Undergoes STUB1-mediated ubiquitination and degradation.
Subcellular Location
Cytoplasm, Nucleus.
Synonyms
DKFZP586N0721 antibody
DKFZp686J10186 antibody
hMAD 3 antibody
hMAD-3 antibody
hSMAD3 antibody
HSPC193 antibody
HST17436 antibody
JV15 2 antibody
JV15-2 antibody
JV152 antibody
ExpandDKFZP586N0721 antibody
DKFZp686J10186 antibody
hMAD 3 antibody
hMAD-3 antibody
hSMAD3 antibody
HSPC193 antibody
HST17436 antibody
JV15 2 antibody
JV15-2 antibody
JV152 antibody
LDS1C antibody
LDS3 antibody
MAD (mothers against decapentaplegic Drosophila) homolog 3 antibody
MAD homolog 3 antibody
Mad homolog JV15 2 antibody
Mad protein homolog antibody
MAD, mothers against decapentaplegic homolog 3 antibody
Mad3 antibody
MADH 3 antibody
MADH3 antibody
MGC60396 antibody
Mothers against decapentaplegic homolog 3 antibody
Mothers against DPP homolog 3 antibody
SMA and MAD related protein 3 antibody
SMAD 3 antibody
SMAD antibody
SMAD family member 3 antibody
SMAD, mothers against DPP homolog 3 antibody
Smad3 antibody
SMAD3_HUMAN antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of Phospho-Smad3 (S423 + S425) on different lysates with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/5,000 dilution and competitor's antibody at 1/1,000 dilution.
Lane 1: A549 whole cell lysate
Lane 2: A549 treated with 5ng/mL TGF-beta1 for 24 hours whole cell lysate
Lane 3: C2C12 whole cell lysate
Lane 4: C2C12 treated with 5ng/mL TGF-beta1 for 24 hours whole cell lysate
Lysates/proteins at 15 µg/Lane.
Predicted band size: 48 kDa
Observed band size: 55 kDa
Exposure time: 2 minutes; ECL: K1802;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1609-41) at 1/5,000 dilution and competitor's antibody at 1/1,000 dilution were used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of A549 cells labeling Phospho-Smad3 (S423 + S425) with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
☑ Cell treatment (CT)
Western blot analysis of Phospho-Smad3 (S423 + S425) on different lysates with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/2,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: HeLa starved overnight then treated with 10ng/mL TGF-β1 for 30 minutes cell lysate
Lane 3: A549 cell lysate
Lane 4: A549 treated with 5ng/mL TGF-beta1 for 24 hours cell lysate
Lane 5: NIH/3T3 cell lysate
Lane 6: NIH/3T3 starved overnight then treated with 10ng/mL TGF-β1 for 30 minutes cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 48 kDa
Observed band size: 55 kDa
Exposure time: 2 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1609-41) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human large intestine tissue with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1609-41) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse skin tissue with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1609-41) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1609-41) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunofluorescence analysis of paraffin-embedded human large intestine tissue labeling Phospho-Smad3 (S423 + S425) with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS, and then probed with the primary antibody (ET1609-41, green) at 1/200 dilution overnight at 4 ℃, washed with PBS. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. Nuclei were counterstained with DAPI (blue). -
Immunofluorescence analysis of paraffin-embedded mouse kidney tissue labeling Phospho-Smad3 (S423 + S425) with Rabbit anti-Phospho-Smad3 (S423 + S425) antibody (ET1609-41) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS, and then probed with the primary antibody (ET1609-41, green) at 1/200 dilution overnight at 4 ℃, washed with PBS. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. Nuclei were counterstained with DAPI (blue).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Lisinopril activates BI1 to reprogram lipid metabolism and restore autophagy in ALS
Journal: Communications Biology
DOI: 10.1038/s42003-026-09930-2
IF: 5.1
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Osteoblast-derived osteomodulin restrains osteoclastogenesis via ITGB8/RRM2-mediated reduction of mitochondrial respiration and mitochondrial ATP production
Journal: Experimental & Molecular Medicine
DOI: 10.1038/s12276-026-01682-7
IF: 12.9
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Gli2 and Gli3 synergistically mediate HH-TGF-β crosstalk in mesenchymal progenitor cells to orchestrate tooth root morphogenesis
Journal: International Journal Of Oral Science
DOI: 10.1038/s41368-026-00427-6
IF: 12.2
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Integrin inhibition facilitates fibrocartilaginous transformation in connective tissue in osteoarthritis
Journal: Science Advances
DOI: 10.1126/sciadv.ady4112
IF: 12.5
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Mechanisms underlying the role of TNF-α and IL-1β preconditioned exosomes derived from human umbilical cord mesenchymal stem cells in wound healing
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2026.1713004
IF: 5.9
Application: IF-tissue
Reactivity: Human,Mouse
Publish date: 2026 Feb
-
Identification and validation of a novel estrogen-related model for breast cancer to predict the prognosis
Journal: Translational Cancer Research
DOI: 10.21037/tcr-2025-1409
IF: 1.7
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
Targeting USP4 to inhibit TGF-β signaling: the antifibrotic potential of isovitexin in renal interstitial fibrosis
Journal: Journal of Biomaterials Science, Polymer Edition
DOI: 10.1016/j.phymed.2026.158141
IF: 8.3
Application: IHC,WB
Reactivity: Mouse,Human,Rat
Publish date: 2026 Apr
-
ECM remodeling features in reparative chondrocytes during knee osteoarthritis
Journal: Frontiers In Endocrinology
DOI: 10.3389/fendo.2026.1773139
IF: 4.6
Application: WB
Reactivity: Human
Publish date: 2026 Apr
-
HIC2 suppresses glioblastoma progression via transcriptional repression of SEMA3A and inhibition of TGF-β signaling
Journal: Free Radical Biology And Medicine
DOI: 10.1016/j.freeradbiomed.2025.09.007
IF: 8.2
Application: WB
Reactivity: Human
Publish date: 2025 Sept
-
Immune landscape and molecular regulators in renal interstitial fibrosis
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115702
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Oct
-
Salvianolic acid A enhances Treg accumulation via the RUNX1/CBFβ/FOXP3 axis as a neuroprotective immunomodulator in ischemic stroke
Journal: Archives of Pharmacal Research
DOI: 10.1007/s12272-025-01576-8
IF: 7.5
Application: WB
Reactivity: Mouse
Publish date: 2025 Nov
-
Autophagic degradation of SQSTM1 enables fibroblast activation to accelerate wound healing
Journal: Autophagy
DOI: 10.1080/15548627.2025.2508546
IF: 14.6
Application: WB
Reactivity: Human,Mouse
Publish date: 2025 May
-
Vaccarin Ameliorates Renal Fibrosis by Inhibiting Ferroptosis via Nrf2/SLC7A11/GPX4 Signaling Pathway
Journal: Drug Design Development And Therapy
DOI: 10.2147/DDDT.S509357
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Mar
-
Tryptanthrin alleviate lung fibrosis via suppression of MAPK/NF-κB and TGF-β1/SMAD signaling pathways in vitro and in vivo
Journal: Toxicology And Applied Pharmacology
DOI: 10.1016/j.taap.2025.117285
IF: 3.3
Application: WB
Reactivity: Mouse
Publish date: 2025 Mar
-
Activin A exacerbates neonatal necrotizing enterocolitis via ALK4-mediated apoptosis and barrier disruption
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115043
IF: 4.7
Application: IF-cell
Reactivity: Mouse,Rat
Publish date: 2025 Jun
-
IGFBP2 up-regulation by EBV via TGF-β signaling: a key mechanism in nasopharyngeal carcinoma progression
Journal: Virus Genes
DOI: 10.1007/s11262-025-02178-8
IF: 1.9
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
Vincristine Regulates C/EBP-β/TGF-β1 to Promote A1 Astrocyte Polarization and Induce Neuropathic Pain
Journal: Drug Design Development And Therapy
DOI: 10.2147/DDDT.S504873
IF: 4.7
Application: WB
Reactivity: Rat
Publish date: 2025 Feb
-
Curcumin Alleviates the Effects of Heat Stress on Broiler Pectoral Muscle via Decorin (DCN) -Mediated TGF-β Signaling Pathway
Journal: Poultry Science
DOI: 10.1016/j.psj.2025.106231
IF: 4.2
Application: WB
Reactivity: Chicken
Publish date: 2025 Dec
-
PH20-modified exosomes loaded curcumin inhibit desmoplastic breast cancer by breaking extracellular matrix barrier and normalizing cancer-associated fibroblasts
Journal: Materials Today Bio
DOI: 10.1016/j.mtbio.2025.102635
IF: 10.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Dec
-
Cranial base synostosis in mice caused by upregulation of Wnt following partial inhibition of Shh
Journal: BMC Biology
DOI: 10.1186/s12915-025-02381-x
IF: 4.5
Application: IF-tissue
Reactivity: Mouse
Publish date: 2025 Aug
-
Cepharantine prevents hypertrophic scarring by regulating the TGF-β/SMAD pathway
Journal: Archives Of Dermatological Research
DOI: 10.1007/s00403-025-04120-2
IF: 1.8
Application: WB
Reactivity: Human
Publish date: 2025 Apr
-
Biosynthesis of the Natural Antioxidant Mycosporine-Glycine and Its Anti-Photodamage Properties
Journal: Journal Of Agricultural And Food Chemistry
DOI: 10.1021/acs.jafc.5c03351
IF: 5.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Apr
-
ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway
Journal: Pulmonary Pharmacology & Therapeutics
DOI:
IF: 6.9
Application: WB
Reactivity: Human
Publish date: 2024 Nov
-
ARHGAP4 promotes colon cancer metastasis through the TGF-β signaling pathway and may be associated with T cell exhaustion
Journal: Biochemical And Biophysical Research Communications
DOI:
IF: 3.1
Application: WB
Reactivity: Human
Publish date: 2024 May
-
PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis
Journal: Inflammation
DOI:
IF: 5.1
Application: WB
Reactivity: Mouse
Publish date: 2024 May
-
RRM2 Regulates Hepatocellular Carcinoma Progression Through Activation of TGF-β/Smad Signaling and Hepatitis B Virus Transcription
Journal: Genes
DOI:
IF: 2.8
Application: WB
Reactivity: Mouse
Publish date: 2024 Dec
-
Tanshinone I improves renal fibrosis by promoting gluconeogenesis through upregulation of peroxisome proliferator-activated receptor-γ coactivator 1α
Journal: Chronic Kidney Disease And Progression
DOI:
IF: 3
Application: WB
Reactivity: Human
Publish date: 2024 Dec
-
Experimental study on H2O2 activation of HSC-T6 and hepatic fibrosis in cholestatic mice by "Yajieshaba"
Journal: Journal Of Ethnopharmacology
DOI:
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2024 Aug
-
Suppression of NUPR1 in fibroblast-like synoviocytes reduces synovial fibrosis via the Smad3 pathway
Journal: Journal Of Translational Medicine
DOI:
IF: 6.1
Application: WB
Reactivity: Mouse
Publish date: 2024 Aug
-
Knockdown of Secernin 1 inhibit cell invasion and migration by activating the TGF-β/Smad3 pathway in oral squamous cell carcinomas
Journal: Scientific Reports
DOI:
IF: 4.6
Application: WB
Reactivity: Human
Publish date: 2023 Sept
-
Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro
Journal: Journal Of Advanced Research
DOI:
IF: 10.7
Application: IHC-P
Reactivity: Mouse
Publish date: 2023 Sep
-
SDMA attenuates renal tubulointerstitial fibrosis through inhibition of STAT4
Journal: Journal Of Translational Medicine
DOI:
IF: 8.440
Application: WB
Reactivity: Mouse
Publish date: 2023 May
-
Salvianolic Acid C Inhibits the Epithelial-Mesenchymal Transition and Ameliorates Renal Tubulointerstitial Fibrosis
Journal: Frontiers In Bioscience-Landmark
DOI: 10.31083/j.fbl2806121
IF: 3.1
Application: WB
Reactivity: Mouse
Publish date: 2023 Jun
-
Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL
Journal: Advanced Science
DOI:
IF: 15.1
Application: WB
Reactivity: Mouse
Publish date: 2023 Jul
-
Fibulin-3 regulates the inhibitory effect of TNF-α on chondrocyte differentiation partially via the TGF-β/Smad3 signaling pathway
Journal: Biochimica Et Biophysica Acta - Molecular Cell Research
DOI:
IF: 5.1
Application: WB
Reactivity: Mouse
Publish date: 2022 Sep
-
TGF-β-Containing Small Extracellular Vesicles From PM2.5-Activated Macrophages Induces Cardiotoxicity
Journal: Frontiers In Cardiovascular Medicine
DOI:
IF: 5.846
Application: WB
Reactivity: Mouse
Publish date: 2022 Jul
-
Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways
Journal: Frontiers In Pharmacology
DOI:
IF: 5.810
Application: WB
Reactivity: Mouse
Publish date: 2022 Jan
-
Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A
Journal: BMC Complementary Medicine and Therapies
DOI:
IF: 2.838
Application: WB
Reactivity: Mouse
Publish date: 2022 Apr
-
TBX20 Contributes to Balancing the Differentiation of Perivascular Adipose-Derived Stem Cells to Vascular Lineages and Neointimal Hyperplasia
Journal: Frontiers In Cell And Developmental Biology
DOI:
IF: 5.20
Application: WB,IF-cell
Reactivity: Mouse
Publish date: 2021 Jun
-
Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys. Frontiers in pharmacology, 12, 626510.
Journal: Frontiers In Pharmacology
DOI:
IF: 5.814
Application: WB
Reactivity: Rat
Publish date: 2021 Jul
-
Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2021.636154
IF: 5.811
Application: WB
Reactivity: Rat
Publish date: 2021 Feb
-
Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling. International immunopharmacology, 91, 107279.
Journal: International Immunopharmacology
DOI:
IF: 3.94
Application: WB
Reactivity: Mouse
Publish date: 2021 Feb
-
Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model
Journal: Drug Design Development And Therapy
DOI:
IF: 3.22
Application: WB
Reactivity: Rat
Publish date: 2020 Jun
-
FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors
Journal: Aging (Albany Ny)
DOI:
IF: 5.52
Application: WB
Reactivity: Human
Publish date: 2020 Jan